Across
- 5. Mechanismofactionofphentermineresin norepinephrine releasing agent
- 6. CLINICALANDMETABOLICFACTORS METABOLIC SYNDROME
- 8. NONADIPOSETISSUE LIPOTOXICITY
- 10. fataccumulationareclassificationof Body mass index
- 11. LESSTHANOREQUALTO40KG/SQ.MWHICH CLASSOfOBESITY CLASS 3
- 13. DASHstudieseffect -5.5and -3.0mm hgforsystolicanddiastolicwhichisfor. Combination diet
- 15. leptinandadeponectinsecretedby whiteadipocytes
- 17. 10 mg twice a day
- 19. CLINICALBENEFITSOFOBISITY PHARMACOKINITICSSIBUTRAMINEDELAYS DIABETES.
- 21. performedinUS. Threee
Down
- 1. predisposingfactorfor. Obesity
- 2. obesity
- 3. weekofaerobicactivity. 200-300min
- 4. OREXIGENICHORMONEANDSTIMULATE APPETITE GHRELIN
- 7. metabolicsyndromeanddiabetesby30-40 percent orlistat
- 9. howmanyelementsusedforthedevelopmentof metabolicsyndrome two
- 10. Weightlosslowcaloriediettypicallyforwomen in2013guidely 1200-1500kcal per day
- 12. healthy obesity
- 13. rangelessthan18.5kg/sq.mwhichisfor. Underweight
- 14. CARDIOMETABOLIC DISEASE
- 16. DIAGNOSISOFMETABOLICSYNDROMEFOR RAISEDHDLCHOLESTEROLNOTINCLUDEDIN INTERNATIONAL DIABETES REDUCTION
- 18. Thephenotypeinwhich30%ofobeseindividuals arefreeofmetabolicco-morbidities
- 20. mostwidelyacceptedcriteriaformetabolic syndromeusing waistcircumference